U.S. market Closed. Opens in 1 day 6 hours 36 minutes

VIR | Vir Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue86.18M1.58B1.09B67.25M711.00K868.00K149.00K
Cost of Revenue2.77M146.32M65.86M301.58M148.47M100.23M62.51M
Gross Profit83.42M1.43B1.02B-234.33M-147.76M-99.36M-62.36M
Operating Expenses767.72M601.09M600.45M364.23M178.69M119.56M81.65M
Selling, General & Admin174.05M161.76M160.79M70.94M37.60M29.13M21.69M
Research & Development589.67M474.65M448.01M302.41M148.47M100.23M62.51M
Other Operating ExpensesN/A-35.33M-8.35M-9.12M-7.38M-212.00K83.00K
Operating Income-684.30M833.07M276.89M-296.98M-177.98M-118.69M-81.50M
Other Expenses / Income56.11M-78.79M129.05M-1.63M3.45M2.33M721.00K
Before Tax Income-628.19M754.28M549.80M-298.61M-174.53M-116.36M-80.78M
Income Tax Expenses-13.08M238.44M21.22M54.00K154.00K-480.00K-10.92M
Net Income-615.06M515.84M528.58M-298.67M-174.68M-115.88M-69.85M
Interest ExpensesN/A183.15MN/AN/AN/AN/AN/A
Basic Shares Outstanding134.13M132.61M129.88M119.16M107.65M96.91M96.91M
Diluted Shares Outstanding134.13M134.81M133.44M119.16M107.65M96.91M96.91M
EBITDA-664.85M833.07M420.75M-289.80M-173.46M-115.94M-81.06M
EBITDA Margin-771.47%52.71%38.71%-430.96%-24,396.91%-13,356.68%-54,406.04%
EBIT-628.14M937.42M549.80M-298.61M-174.53M-116.36M-80.78M
EBIT Margin-728.87%59.31%50.58%-444.06%-24,546.98%-13,405.99%-54,212.08%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙